Jesse Kaye, PhD

Publications by Dr. Jesse Kaye

Jesse Kaye, PhD, is a Scientist at the University of Wisconsin Center for Tobacco Research and Intervention (UW-CTRI) and member of the UW Carbone Cancer Center, Cancer Prevention and Control Program.

Dr. Kaye’s research on tobacco and other substance use disorders focuses on understanding mechanisms that maintain addiction and using this knowledge to develop treatments that are more effective. He examines psychological and neurobiological processes related to risk, etiology, and treatment common across addictive disorders. His research on tobacco addiction specifically aims to enhance tobacco treatment for populations who bear greater consequences from smoking, such as those who: use other substances; live with mental illness or chronic pain; and are incarcerated.

Kaye’s research incorporates a diverse toolbox including data science, human laboratory neuroscience, treatment clinical trials, psychopharmacology, psychotherapy, mHealth and mobile data collection (e.g., ecological momentary assessments), and psychometric evaluation (e.g., self-report scale development, physiology assessments). Dr. Kaye is an Academic Editor for the journal PLOS ONE and has a commitment to promoting scientific rigor, robustness, and reproducibility.

Kaye obtained his PhD in Clinical Psychology at the University of Wisconsin – Madison in 2018. He completed his clinical psychology internship and advanced postdoctoral fellowship in addiction treatment and research at the William S. Middleton Memorial Veterans Hospital (Madison VA). He was awarded two individual predoctoral training grants from the Graduate Research Fellowship Program at the National Science Foundation (NSF) and the Ruth L. Kirschtein Predoctoral Individual National Research Service Award (NRSA, F31) from the National Institute on Alcohol Abuse and Alcoholism (NIAAA).

Kaye is a licensed clinical psychologist.

Representative Publications:

• Kaye JT, Kirsch JA, Bolt DM, Kobinsky KH, Vickerman KA, Mullis K, Fraser DL, Baker TB, Fiore MC, McCarthy DE. (2024) Tobacco Quitline Retreatment Interventions Among Adults With Socioeconomic Disadvantage: A Factorial Randomized Clinical Trial. JAMA Network Open. 7(11):e2443044. Online November 6, 2024.
• Kaye JT, Johnson AL, Piper ME, Baker TB, & Cook JW (2020). Searching for Personalized Medicine for Binge Drinking Smokers: Smoking Cessation Using Varenicline, Nicotine Patch, or Combination Nicotine Replacement Therapy. Journal of Studies on Alcohol and Drugs, 81, 426-435. doi: 10.15288/jsad.2020.81.426. PMID: 32800078. PMCID: PMC7437557.
• Fronk GE, Sant’Ana SJ, Kaye JT, & Curtin JJ (2020). Stress Allostasis in Substance Use Disorders: Promise, Progress, and Emerging Priorities in Clinical Research. Annual Review of Clinical Psychology, 16, 401-430. doi: 10.1146/annurev-clinpsy-102419-125016; PMID: 32040338. PMCID: PMC7259491.
• Kaye JT, Bradford DE, Magruder KP, & Curtin JJ (2017). Probing for Neuroadaptations to Unpredictable Stressors in Addiction: Translational Methods and Emerging Evidence. Journal of Studies on Alcohol and Drugs, 78, 353-371. doi: 10.15288/jsad.2017.78.353; PMID: 28499100. PMCID: PMC5440361.